Loading...

Compass Pathways Plc ($CMPS)

Stock Image

CMPS Overview

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States.It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020.COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom. (From: StockAnalysis.com)

MORE ABOUT Compass Pathways Plc

Stay up to date with the best of Bullish each week.

BULLISH WEEKLY

Stay up to date with the best of Bullish each week.